Solid Tumors Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Tucson, Arizona
  • +18 more
2021-11-17
Nov 17, 2021
S
Recruiting
  • Solid Tumors
  • 68Ga-NODAGA-SNA006
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-11-08
Nov 8, 2021
A
Active, not recruiting
  • Solid Tumors
  • Milano, Italy
  • +2 more
2021-11-17
Nov 17, 2021
N
Enrolling by invitation
  • Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-11-17
    Nov 17, 2021
    B
    Recruiting
    • Solid Tumors
    • Regorafenib, (Stivarga, BAY73-4506)
    • Nivolumab (Opdivo)
    • Duarte, California
    • +38 more
    2021-11-17
    Nov 17, 2021
    M
    Completed
    • Solid Tumors
    • Relapsed/Refractory Sarcomas
    • Vorinostat and Etoposide
    • Phoenix, Arizona
    • +10 more
    2021-10-19
    Oct 19, 2021
    R
    Recruiting
    • Solid Tumors
    • Irvine, California
    • +7 more
    2021-11-15
    Nov 15, 2021
    H
    I
    Active, not recruiting
    • Biliary Tract Cancer (BTC)
    • +5 more
    • Birmingham, Alabama
    • +9 more
    2021-11-11
    Nov 11, 2021
    R
    Recruiting
    • Solid Tumors
    • Houston, Texas
      MD Anderson Cancer Center
    2021-11-08
    Nov 8, 2021
    T
    Recruiting
    • Solid Tumors
    • TAK-102
    • Kashiwa, Chiba, Japan
    • +1 more
    2021-11-02
    Nov 2, 2021
    P
    Recruiting
    • Ewing Sarcoma
    • +6 more
    • Birmingham, Alabama
    • +57 more
    2021-11-02
    Nov 2, 2021
    H
    Recruiting
    • Solid Tumors
    • Shanghai City, China
      Fudan University Shanghai Cancer Center
    2021-11-08
    Nov 8, 2021
    H
    Active, not recruiting
    • Solid Tumors
    • Melbourne, Victoria, Australia
    • +10 more
    2021-11-05
    Nov 5, 2021